Veteran investor and operator with a focus on growth-stage companies, M&A and board-level performance improvement, Kevin Galvin leverages a blend of operational leadership and transaction experience to advise and scale technology and services businesses. He is known for driving revenue-focused transformations, structuring growth financings, and supporting CEO teams through exits and strategic partnerships. Market-facing profile suits roles in private equity, growth equity or corporate development and frequent participation on governance and advisory bodies.
Veteran investor and operator with a focus on growth-stage companies, M&A and board-level performance improvement, Kevin Galvin leverages a blend of operational leadership and transaction experience to advise and scale technology and services businesses. He is known for driving revenue-focused transformations, structuring growth financings, and supporting CEO teams through exits and strategic partnerships. Market-facing profile suits roles in private equity, growth equity or corporate development and frequent participation on governance and advisory bodies.
Prioritizes growth-stage technology and services companies where operational intervention and deal structuring can unlock revenue and valuation upside. Emphasizes active board-level partnership, KPI-driven commercial turnarounds, and structuring growth financings that align management incentives with exit or strategic-partner scenarios. Uses a transaction-minded, operator lens to underwrite opportunities—favoring repeatable revenue models, clear paths to margin expansion, and defensible customer relationships. Time horizon is variable but outcome-focused, blending mid-term value creation with disciplined downside protection via covenants, earn-outs, and staged capital deployment.
Prioritizes growth-stage technology and services companies where operational intervention and deal structuring can unlock revenue and valuation upside. Emphasizes active board-level partnership, KPI-driven commercial turnarounds, and structuring growth financings that align management incentives with exit or strategic-partner scenarios. Uses a transaction-minded, operator lens to underwrite opportunities—favoring repeatable revenue models, clear paths to margin expansion, and defensible customer relationships. Time horizon is variable but outcome-focused, blending mid-term value creation with disciplined downside protection via covenants, earn-outs, and staged capital deployment.
| Trades 890 | Longs Won 632/890 71% | Profit Factor 19.94 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $272,589.02 |
| Average Win $59,974 | Best Trade (Aug 28) $5.08M | Sharpe Ratio -10.72 |
| Average Loss -$7,367.04 | Worst Trade (Aug 28) -$170,376.65 | Z-Score 8.81 (100%) |
| Commissions $0 | Avg. Trade Length 10m 2d | Expectancy $40,452.67 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 23,810 | 21,429 | 19,048 | 16,667 | 14,286 | 11,905 | 9,524 | 7,143 | 4,762 | 2,381 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
AAPL Apple Inc. | 7,229 | $1.79M | $2.23M | - | $438,691.38 | 24.45% | -7.354% |
ABBV AbbVie Inc. | 1,661 | $295,160.36 | $416,811.34 | - | $121,650.98 | 41.22% | -2.513% |
ABT Abbott Laboratories | 2,819 | $322,565.81 | $297,968.3 | - | -$24,597.51 | -7.63% | +0.085% |
ACWX ISHARES MSCI ACWI EX U.S. ETF | 138,864 | $9.63M | $10.45M | - | $823,685.25 | 8.56% | -0.172% |
AMGN Amgen Inc. | 1,729 | $455,388.65 | $665,941.64 | - | $210,552.99 | 46.24% | -0.64% |
AMZN Amazon.com Inc | 2,811 | $608,662.78 | $763,411.35 | - | $154,748.57 | 25.42% | +15.321% |
AON Aon plc | 745 | $265,239.76 | $268,609.74 | - | $3,369.98 | 1.27% | -1.642% |
AUB Atlantic Union Bankshares Corporation | 11,231 | $351,305.72 | $476,531.33 | - | $125,225.61 | 35.65% | +0.355% |
AVGO Broadcom Inc. | 532 | $200,963 | $207,096.96 | - | $6,133.96 | 3.05% | +0.371% |
AXP American Express Company | 852 | $252,865.56 | $286,485 | - | $33,619.44 | 13.3% | -0.376% |
BKNG Booking Holdings Inc. | 1,351 | $267,081.53 | $260,607.89 | - | -$6,473.64 | -2.42% | -0.176% |
BND Vanguard Total Bond Market Index Fund | 7,635 | $549,093.47 | $551,476.05 | - | $2,382.58 | 0.43% | -0.262% |
BSV Vanguard Short-Term Bond ETF | 144,402 | $11.37M | $11.2M | - | -$169,757.93 | -1.49% | -0.077% |
BX Blackstone Inc. | 1,890 | $325,889.24 | $241,447.5 | - | -$84,441.74 | -25.91% | -0.25% |
CAT Caterpillar Inc. | 315 | $114,264.88 | $256,665.15 | - | $142,400.27 | 124.62% | +0.701% |
CGDV Capital Group Dividend Value ETF | 47,609 | $2.05M | $2.36M | - | $304,960.09 | 14.85% | +0.63% |
CGGR Capital Group Growth ETF | 95,742 | $3.63M | $4.29M | - | $660,983.91 | 18.19% | +0.651% |
CGXU Capital Group International Focus Equity ETF | 622,577 | $16.07M | $20.84M | - | $4.77M | 29.65% | -0.535% |
CL Colgate-Palmolive Company | 3,270 | $297,276 | $298,551 | - | $1,275 | 0.43% | -0.328% |
COST Costco Wholesale Corporation | 445 | $408,181.87 | $423,591.05 | - | $15,409.18 | 3.78% | -0.239% |